Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cranney

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|March 15, 2001
Discrimination of changes in osteoporosis outcomesA Cranney, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Bisphosphonates for steroid induced osteoporosisJ Homik, A Cranney, B Shea, et al.
The Journal of Rheumatology|February 24, 2001
The psychometric properties of patient preferences in osteoporosisA Cranney, D Coyle, B A Pham, et al.
The Journal of Rheumatology|January 26, 1999
Responsiveness of endpoints in osteoporosis clinical trials--an updateA Cranney, V Welch, P Tugwell, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG Wells, A Cranney, J Peterson, et al.
BMC Musculoskeletal Disorders|August 14, 2002
Systematic assessment of the quality of osteoporosis guidelinesA Cranney, L Waldegger, I D Graham, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Etanercept for the treatment of rheumatoid arthritisB Blumenauer, M Judd, A Cranney, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG A Wells, A Cranney, J Peterson, et al.
Patient Education and Counseling|November 4, 2008
Osteoporosis risk perceptions among patients who have sustained a fragility fractureLora Giangregorio, L Dolovich, A Cranney, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG A Wells, A Cranney, J Peterson, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|March 15, 2001
Discrimination of changes in osteoporosis outcomesA Cranney, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Bisphosphonates for steroid induced osteoporosisJ Homik, A Cranney, B Shea, et al.
The Journal of Rheumatology|February 24, 2001
The psychometric properties of patient preferences in osteoporosisA Cranney, D Coyle, B A Pham, et al.
The Journal of Rheumatology|January 26, 1999
Responsiveness of endpoints in osteoporosis clinical trials--an updateA Cranney, V Welch, P Tugwell, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG Wells, A Cranney, J Peterson, et al.
BMC Musculoskeletal Disorders|August 14, 2002
Systematic assessment of the quality of osteoporosis guidelinesA Cranney, L Waldegger, I D Graham, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Etanercept for the treatment of rheumatoid arthritisB Blumenauer, M Judd, A Cranney, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG A Wells, A Cranney, J Peterson, et al.
Patient Education and Counseling|November 4, 2008
Osteoporosis risk perceptions among patients who have sustained a fragility fractureLora Giangregorio, L Dolovich, A Cranney, et al.
The Cochrane Database of Systematic Reviews|February 7, 2008
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenG A Wells, A Cranney, J Peterson, et al.
Pageof 6